GlassScriptPhysician profile
Donald A Durecki
NPI 1982648721
$871.31
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $148 · 2021: $300 · 2022: $302.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $503.52 | 2019-2022 | |
| Organon LLC | $82.98 | 2021-2022 | |
| Amgen INC. | $62.84 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $45.81 | 2022 | |
| Therapeuticsmd, INC. | $37.76 | 2021-2022 | |
| Duchesnay USA Incorporated | $33.33 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.46 | 2021-2022 | |
| Allergan, INC. | $24.99 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $17.79 | 2021 | |
| Hologic Sales and Service, LLC | $12.33 | 2019 | |
| Minerva Surgical, INC | $11.29 | 2021 | |
| Pfizer INC. | $11.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Durecki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.